SCHEDULE OF COMMON STOCK PURCHASE WARRANTS ISSUED AND OUTSTANDING (Details) - $ / shares |
12 Months Ended | ||
---|---|---|---|
Sep. 01, 2020 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Equity [Abstract] | |||
Warrants Outstanding, Beginning balance | 57,043,836 | 51,066,864 | |
Weighted Average Exercise Price, Ending balance | $ 0.14 | $ 0.20 | |
Warrants Outstanding, Granted | 1,000,000 | 18,650,000 | 12,250,000 |
Weighted Average Exercise Price, Granted | $ 0.15 | $ 0.15 | |
Warrants Outstanding, Exercised | (1,650,000) | (125,000) | |
Weighted Average Exercise Price, Exercised | $ 0.08 | $ 0.09 | |
Warrants Outstanding, Expired | (33,279,170) | (6,148,028) | |
Weighted Average Exercise Price, Expired | $ 0.19 | $ 0.25 | |
Warrants Outstanding, Ending balance | 40,764,666 | 57,043,836 | |
Weighted Average Exercise Price, Ending balance | $ 0.13 | $ 0.14 |
X | ||||||||||
- Definition Weighted average exercise price, expired. No definition available.
|
X | ||||||||||
- Definition Warrants weighted average exercise price. No definition available.
|
X | ||||||||||
- Definition Weighted average exercise price, exercised. No definition available.
|
X | ||||||||||
- Definition Weighted average exercise price, granted. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|